Vitality Watch

Dossier rss observational 26-sep-2026
Human cohort, case-control, or epidemiological association

A Deep‐Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes

Key claim: A deep-learning biomarker of systemic cellular senescence burden predicts mortality and health outcomes.

Abstract

Aging Cell, Volume 25, Issue 10, October 2026.

Why this matters

Senescent-cell burden has been a mechanistically important but hard-to-measure target; most existing readouts are imaging probes or single analytes without outcome linkage. A deep-learning composite that ties systemic senescence signals to mortality moves the field toward an outcome-anchored senescence metric, which matters because senolytic trials currently lack a validated pharmacodynamic biomarker. As with any clock, associating the score with mortality is not the same as showing that moving it reflects reduced senescent burden or extended healthspan.

Source

Link

Briefing card

A Deep‐Learning Based Biomarker of Systemic Cellular Senescence Burden to Predict Mortality and Health Outcomes
Stage: observational · rss · 26-sep-2026

If you're tracking senolytic or senescence-targeted interventions, this is an observational mortality-linked score, not a validated readout that intervention-driven changes mean less senescence.

A deep-learning biomarker of systemic cellular senescence burden predicts mortality and health outcomes.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: url:https://onlinelibrary.wiley.com/doi/10.1111/acel.70737?af=R

build build 880 · 2bcef25 · 2026-11-18